These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5935729)

  • 1. Assay of antituberculosis drugs in tuberculous patients.
    Kent DC
    Dis Chest; 1966 Jun; 49(6):595-9. PubMed ID: 5935729
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peculiarities of PAS and tubazid metabolism in tuberculous patients treated with nerobol and ATP].
    Sabula MM
    Probl Tuberk; 1972; 50(1):47-50. PubMed ID: 5010779
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concentration and excretion of isoniazid and PAS in patients with tuberculosis depending on the functional status of the kidney].
    Savula MM; Kiselova ES
    Vrach Delo; 1978 May; (5):119-22. PubMed ID: 676253
    [No Abstract]   [Full Text] [Related]  

  • 5. [Functional state of the liver and the metabolism of isoniazid and PASA in adolescents with intrathoracic tuberculosis].
    Tytor IaN
    Probl Tuberk; 1976 Jul; (7):29-32. PubMed ID: 959195
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis].
    Tytor IaM
    Probl Tuberk; 1975; (7):51-4. PubMed ID: 1082592
    [No Abstract]   [Full Text] [Related]  

  • 7. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 8. [Liver function and INH and PAS metabolism in tuberculous adolescents with side reactions to chemotherapy].
    Tytor IaN; Koropetskiĭ VI
    Vrach Delo; 1977 Jun; (6):61-4. PubMed ID: 883281
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration.
    Kreukniet J; Blom van Assendelft PM; Mouton RP; Tasman A; Bangma PJ
    Scand J Respir Dis; 1966; 47(4):236-43. PubMed ID: 5182291
    [No Abstract]   [Full Text] [Related]  

  • 10. [Excretion and concentration of tubazid, PAS and their metabolites in patients with tuberculosis and different functional conditions of kidneys].
    Savula MM
    Sov Med; 1973 Sep; 36(9):146-7. PubMed ID: 4756491
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification of the serum isoniazid levels by different preparations of paraaminosalicylic acid.
    Tiitinen H; Mattila MJ
    Arzneimittelforschung; 1968 May; 18(5):623-5. PubMed ID: 5755895
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J
    Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacogenetic and interaction-model with some usual antitubercular agents].
    Hanngren A; Boman G; Borgå O; Malmborg AS; Sjöqvist F
    Nord Med; 1970 Sep; 84(38):1204. PubMed ID: 5469274
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acetylation of p-aminosalicylic acid and isoniazid in the perfused liver as a competitive enzymatic process].
    Wagner J; Dolezal V
    Acta Univ Carol Med (Praha); 1965; ():Suppl 21:165+. PubMed ID: 5880954
    [No Abstract]   [Full Text] [Related]  

  • 15. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
    Mariani B; Bisetti A; Monzali G
    G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acetylation phenotype and biotransformation of various drugs].
    Grygorowicz J; Januszko J
    Wiad Lek; 1987 Mar; 40(5):319-23. PubMed ID: 3303698
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability of antituberculosis drugs in Löwenstein-Jensen medium.
    Clark J
    J Med Lab Technol; 1967 Jul; 24(3):212-3. PubMed ID: 4292493
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of drug intolerance to antituberculosis chemotherapy.
    Neff TA; Coan BJ
    Dis Chest; 1969 Jul; 56(1):10-2. PubMed ID: 5789831
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative studies with isoniazid alone, isoniazid with thiacetazone and isoniazid with para-aminosalicylic acid in ambulatory treatment of pulmonary tuberculosis.
    Patel RB; Patel TL; Mehta HC
    J Indian Med Assoc; 1967 May; 48(10):471-8. PubMed ID: 4167188
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary resistance to the major drugs in tuberculous patients, in 1961-1966.
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Pol Med J; 1969; 8(5):1131-5. PubMed ID: 4986628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.